2019 Annual Cancer Treatment-Related Adverse Events Symposium

Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.

The target audience for this symposium includes MDs, PAs, NPs, RNs, Pharmacists, and other professionals treating cancer patients and their associated symptoms.

Symposium Highlights 

• Therapy-related adverse events will affect the majority of cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
• With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention.
• Lectures focused on immune-related adverse events will describe clinical presentation, diagnosis, and management strategies for the oncology healthcare provider.
• Up-to-date information will be presented on adverse event mechanisms and management from specialists in the most commonly affected organ systems.
• Practical strategies to maintain patients’ quality of life and dose intensity will be highlighted for the most frequently occurring events.

Live Simulcast Available*

We are pleased to offer a live simulcast option for the 2019 Annual Cancer Treatment-Related Adverse Events Symposium. CME and ABIM MOC credit is offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge so we are happy to offer the live simulcast as an option. Registration for the simulcast is required; to register, please select the "Live Simulcast" option during course registration.

This symposium is endorsed by the Multinational Association of Supportive Care in Cancer.

1. Recognize the clinical presentation and impact on quality of life of treatment-related adverse events
2. Understand mechanisms and interventions to prevent and treat adverse events
3. Discuss procedures and clinical tools to assess treatment-related toxicities in cancer patients

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

Registration Discounts/Promotions

• MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected].

After your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

Please note that registration for the simulcast is non-refundable.

For all other orders, if you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]). 

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

*The live simulcast is for streaming use only. By watching this Simulcast you acknowledge that Memorial Sloan Kettering Cancer Center retains all rights, titles and interest in to all copyrights, trademarks, trade secrets, patents and any other proprietary rights to the content of this material. You are not authorized to record this event. You agree to prevent any unauthorized copying, recording, use, distribution and/or re-broadcast of this live simulcast.

MSK Course Director

Mario E. Lacouture, MD
Member, Memorial Hospital
Dermatology Service

Organizing Committee

Course Faculty 

Faculty Disclosures (All Faculty)

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants or financial support for this live activity:

• AstraZeneca
  Dignitana
• Merck
• PAXMAN Scalp Cooling